share_log

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stanker James H

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Processa Pharmaceuticals | 4:持股變動聲明
美股sec公告 ·  04/13 04:59
牛牛AI助理已提取核心訊息
On January 1, 2024, James H. Stanker, the Chief Financial Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a stock transaction involving the company's common stock. Stanker acquired 1,675 shares through the exercise or conversion of derivative securities. On the same day, he disposed of 518 shares at a price of $2.79 per share, which was part of a transaction to cover exercise prices or tax liabilities. Following these transactions, Stanker's direct holdings in Processa Pharmaceuticals amounted to 6,120 shares. The total market value of the disposed shares was calculated at $1,445.22.
On January 1, 2024, James H. Stanker, the Chief Financial Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a stock transaction involving the company's common stock. Stanker acquired 1,675 shares through the exercise or conversion of derivative securities. On the same day, he disposed of 518 shares at a price of $2.79 per share, which was part of a transaction to cover exercise prices or tax liabilities. Following these transactions, Stanker's direct holdings in Processa Pharmaceuticals amounted to 6,120 shares. The total market value of the disposed shares was calculated at $1,445.22.
2024年1月1日,Processa Pharmicals, Inc.(PCSA)的首席財務官詹姆斯·斯坦克完成了涉及該公司普通股的股票交易。Stanker通過行使或轉換衍生證券收購了1,675股股票。同一天,他以每股2.79美元的價格出售了518股股票,這是支付行使價或納稅義務的交易的一部分。這些交易之後,斯坦克在Processa Pharmicals的直接持股量爲6,120股。已處置股票的總市值計算爲1,445.22美元。
2024年1月1日,Processa Pharmicals, Inc.(PCSA)的首席財務官詹姆斯·斯坦克完成了涉及該公司普通股的股票交易。Stanker通過行使或轉換衍生證券收購了1,675股股票。同一天,他以每股2.79美元的價格出售了518股股票,這是支付行使價或納稅義務的交易的一部分。這些交易之後,斯坦克在Processa Pharmicals的直接持股量爲6,120股。已處置股票的總市值計算爲1,445.22美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。